Area of research
Molecular Biology · Genetics
Research interest
Research interests include Glioma Diagnosis and Treatment, Histone Deacetylase Inhibitors Research, Hedgehog Signaling Pathway Studies, and MicroRNA in disease regulation.
Detection of structural DNA variants in medulloblastomas using optical genome mapping
Strong nuclear expression of HOXB13 is a reliable surrogate marker for DNA methylome profiling to distinguish myxopapillary ependymoma from spinal ependymoma
Strong nuclear expression of HOXB13 is a reliable surrogate marker for DNA methylome profiling to distinguish myxopapillary ependymoma from spinal ependymoma
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma
Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors
The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma
Telomerase reverse transcriptase promoter mutation– and O6-methylguanine DNA methyltransferase promoter methylation–mediated sensitivity to temozolomide in isocitrate dehydrogenase–wild-type glioblastoma: is there a link?
Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses
<i>MiR‐16‐5p</i> is frequently down‐regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma‐Tailored Gene Panel
MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM
Role of micro<scp>RNA</scp>s Located on Chromosome Arm 10q in Malignant Gliomas
Molecular diagnostics of malignant gliomas using next-generation sequencing
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
P02.04 * MICRORNA-MEDIATED DOWN-REGULATION OF NKG2D LIGAND EXPRESSION REDUCES GLIOMA CELL IMMUNOGENICITY
MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma